ELIXIR DIAGNOSTICS, LLC
NPI 1932843836
Clinical Medical Laboratory in Houston, TX

NPI Status: Active since April 26, 2022

Contact Information

17115 RED OAK DR STE 123
HOUSTON, TX
ZIP 77090
Phone: (979) 487-8258
Fax: (832) 413-0059

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 45D2257672
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 04-24-2027

About ELIXIR DIAGNOSTICS, LLC

This page provides the complete NPI Profile along with additional information for Elixir Diagnostics, Llc, a provider established in Houston, Texas operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1932843836 assigned on April 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The authorized official of this NPI record is Mr. Ali Siddiqui (Owner)

NPI
1932843836
Provider Name
ELIXIR DIAGNOSTICS, LLC
Entity Type
Organization
Location Address
17115 RED OAK DR STE 123 HOUSTON, TX 77090
Location Phone
(979) 487-8258
Location Fax
(832) 413-0059
Mailing Address
17115 RED OAK DR STE 123 HOUSTON, TX 77090
Mailing Phone
(979) 487-8258
Mailing Fax
(832) 413-0059
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
04-26-2022
Last Update Date
04-26-2022
Code Navigator

Establishments like Elixir Diagnostics, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

MR. ALI SIDDIQUI

Authorized Official Title
OWNER
Authorized Official Phone
(561) 635-0392

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.

This service was performed 14 times for 14 patients

Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants

Gene analysis for 5,10-methylenetetrahydrofolate reductase (MTHFR) common variants is a test that looks at your DNA to identify any changes in the MTHFR gene. These changes can affect how your body processes certain vitamins, which could impact your overall health.

This service was performed 155 times for 155 patients

Gene analysis (adenomatous polyposis coli), full gene sequence

Gene analysis of the adenomatous polyposis coli (APC) involves studying the entire sequence of the APC gene. This test helps identify mutations that could lead to conditions like familial adenomatous polyposis. The procedure is non-invasive and uses a blood sample.

This service was performed 201 times for 201 patients

Gene analysis (aspartoacylase)

Gene analysis for aspartoacylase is a test that studies your DNA to check for mutations in the ASPA gene. This gene is responsible for producing an enzyme called aspartoacylase, which plays a crucial role in brain development and function. Any changes could lead to health issues.

This service was performed 108 times for 108 patients

Gene analysis (bloom syndrome, recq helicase-like)

Gene analysis for Bloom Syndrome involves studying the RECQ helicase-like gene. This gene is responsible for DNA repair. When it's not working properly, it can lead to Bloom Syndrome, a condition that increases the risk of developing various types of cancer.

This service was performed 321 times for 321 patients

Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants

Gene analysis for breast cancer 1 and 2 involves studying your DNA to detect alterations that may increase your risk of developing certain health issues. This test analyzes the full sequence and checks for duplication or deletion variants.

This service was performed 89 times for 89 patients

Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence

Gene analysis of the calcium voltage-gated channel subunit alpha1 a involves examining your DNA to understand how your body regulates calcium. This helps identify potential health risks related to calcium imbalances. It's a non-invasive procedure involving a simple blood or saliva sample.

This service was performed 144 times for 143 patients

Gene analysis (coagulation factor ix) full sequence analysis

Gene analysis for coagulation factor IX is a process that examines your genes, specifically the one responsible for factor IX - a protein that helps blood clot. It can detect any changes or mutations in this gene, which could affect your body's ability to control bleeding.

This service was performed 317 times for 317 patients

Gene analysis (cystatin b) of full sequence

Gene analysis of the full sequence of Cystatin B is a test that examines your DNA to identify any changes in the Cystatin B gene. This gene is linked to certain health conditions. The analysis helps in diagnosing and tailoring treatment plans.

This service was performed 143 times for 142 patients

Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence

Gene analysis for cystic fibrosis involves examining the entire CFTR gene to identify any changes or mutations that could cause the disease. This can help in diagnosing and managing the condition effectively.

This service was performed 329 times for 329 patients

Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants

Gene analysis of cytochrome P450 2C19 common variants is a test that helps understand how your body processes certain medications. This can help your doctor tailor treatments specifically for you, improving their effectiveness and safety.

This service was performed 53 times for 53 patients

Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants

Gene analysis for cytochrome P450 2C9 common variants is a test to identify specific genetic variations. These variations can affect how your body processes certain medications, helping to determine the most effective and safe drug dosage for you.

This service was performed 53 times for 53 patients

Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants

Gene analysis of cytochrome P450 2D6 (CYP2D6) common variants involves studying specific genes to understand your body's ability to process certain medications. This can help tailor treatments to your unique genetic makeup, optimizing medication effectiveness and safety.

This service was performed 80 times for 80 patients

Gene analysis (fanconi anemia, complementation group c) common variant

Gene analysis for Fanconi Anemia, Complementation Group C, is a test that looks at your DNA to see if you have changes in a specific gene linked to this type of anemia. This can help determine if you have the condition or if you might pass it on to your children.

This service was performed 317 times for 317 patients

Gene analysis (fragile x mental retardation 2) for abnormal alleles

Gene analysis for Fragile X Mental Retardation 2 involves studying your genetic material to identify any unusual changes in a specific gene. This can help determine if you have a particular genetic condition, or if you might pass it on to your children.

This service was performed 108 times for 108 patients

Gene analysis (fragile x mental retardation) abnormal alleles

Gene analysis for Fragile X Mental Retardation involves studying your DNA to identify any abnormal changes or 'alleles'. This helps in detecting the presence of Fragile X syndrome, a genetic condition that can cause learning and behavioral challenges.

This service was performed 108 times for 108 patients

Gene analysis (frataxin) of full sequence

Gene analysis of frataxin involves studying the entire sequence of the frataxin gene. This test helps identify any changes or mutations in the gene that may cause health issues, such as Friedreich's ataxia. It's a non-invasive procedure using a blood sample.

This service was performed 107 times for 107 patients

Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants

Gene analysis of glucose-6-phosphatase, catalytic subunit, common variants involves studying specific genes related to glucose metabolism. This helps understand if you're at risk of certain metabolic disorders. It's a non-invasive procedure, involving a simple blood or saliva sample.

This service was performed 323 times for 323 patients

Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis

Gene analysis for glucose-6-phosphate dehydrogenase (G6PD) involves studying your DNA to check for changes in the G6PD gene. This gene controls an enzyme that helps red blood cells function properly. Anomalies can cause health issues like anemia.

This service was performed 338 times for 336 patients

Gene analysis (glucosidase, beta, acid) common variants

Gene analysis of common variants in the beta-glucosidase acid enzyme helps understand certain health conditions. This enzyme plays a key role in the body's metabolism. By studying its variants, doctors can better diagnose and treat metabolic disorders.

This service was performed 106 times for 106 patients

Gene analysis (hemochromatosis) common variants

Gene analysis for hemochromatosis common variants is a test that checks for specific changes in your DNA. These changes could indicate a higher risk of developing hemochromatosis, a condition that causes your body to absorb too much iron from your diet.

This service was performed 140 times for 140 patients

Gene analysis (hexosaminidase a) common variants

Gene analysis of Hexosaminidase A common variants is a test that examines your DNA for changes in the Hex A gene. This gene is responsible for making an enzyme that breaks down certain substances in the body. Changes in this gene can lead to health issues.

This service was performed 108 times for 108 patients

Gene analysis (huntingtin) for abnormal alleles

Gene analysis for huntingtin examines your DNA to identify if you have abnormal versions of the huntingtin gene. These abnormal genes are associated with Huntington's disease, a nervous system disorder. This test helps in early detection and management.

This service was performed 108 times for 108 patients

Gene analysis (inhibitor of kappa light polypeptide gene enhancer in b-cells, kinase complex-associated protein) common variants

Gene analysis for common variants in the IKBKAP gene helps understand your body's response to certain medications. This non-invasive test studies your DNA to identify variations in this gene, which can influence drug effectiveness and safety.

This service was performed 108 times for 108 patients

Gene analysis (janus kinase 2) targeted sequence analysis

Gene analysis, specifically Janus Kinase 2 (JAK2) targeted sequence analysis, is a lab test that studies a specific gene in your body. It helps identify changes or mutations in the JAK2 gene, which can be linked to certain health conditions. This analysis is performed on a blood or bone marrow sample.

This service was performed 345 times for 344 patients

Gene analysis (methyl cpg binding protein 2) full sequence analysis

Gene analysis, specifically Methyl CpG Binding Protein 2 (MECP2) full sequence analysis, is a detailed examination of your DNA. This test focuses on the MECP2 gene, which plays a crucial role in nerve cell function and development. The results can help identify alterations or mutations that may cause certain health conditions.

This service was performed 151 times for 150 patients

Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10

Gene analysis of the MPL proto-oncogene, thrombopoietin receptor, specifically sequence analysis of exon 10, is a procedure that studies a specific part of your DNA. It helps to identify any changes or mutations that may contribute to certain blood disorders.

This service was performed 345 times for 344 patients

Gene analysis (mutl homolog 1, colon cancer, nonpolyposis type 2) full sequence analysis

Gene analysis, specifically for MUTL Homolog 1, linked to colon cancer, involves studying your DNA sequence. This helps identify any changes or mutations that might increase your risk of developing colon cancer. It's a preventive measure to manage potential health risks.

This service was performed 14 times for 14 patients

Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis

Gene analysis (MUTYH) full sequence analysis is a test that examines your DNA to identify any changes linked to nonpolyposis colon cancer type 1. This can help determine your risk of developing this type of cancer.

This service was performed 166 times for 166 patients

Gene analysis (muts homolog 6 [e coli]) full sequence analysis

Gene analysis, specifically MUTS Homolog 6 (E. coli) full sequence analysis, is a test that examines your DNA to identify changes in the MUTS Homolog 6 gene. This information helps doctors understand and manage potential health concerns.

This service was performed 464 times for 464 patients

Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis

Gene analysis, specifically neurotrophic receptor tyrosine kinase 1 (NTRK1) translocation analysis, is a test that examines your genes for specific changes. These changes could potentially lead to certain health conditions. This analysis helps in providing personalized treatment plans.

This service was performed 110 times for 110 patients

Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis

Gene analysis, specifically neurotrophic receptor tyrosine kinase 2 (NTRK2) translocation analysis, is a test that studies alterations in your genes. This analysis helps identify changes in the NTRK2 gene, which can sometimes be linked to certain health conditions. It's a vital part of personalized medicine.

This service was performed 110 times for 110 patients

Gene analysis (nudix hydrolase 15) for common variants

Gene analysis for Nudix Hydrolase 15 common variants is a genetic test that identifies changes in your NUDT15 gene. These changes can affect how your body responds to certain medications, helping your healthcare provider to personalize your treatment plan.

This service was performed 13 times for 13 patients

Gene analysis (partner and localizer of brca2) full sequence analysis

Gene analysis, specifically for the partner and localizer of BRCA2, involves examining your genetic code to identify any changes in this particular gene. This gene is significant in maintaining the health of your cells. The full sequence analysis means we look at every part of this gene to ensure it's working properly.

This service was performed 518 times for 518 patients

Gene analysis (partner and localizer of brca2) targeted sequence analysis

Gene analysis, specifically the partner and localizer of BRCA2 targeted sequence analysis, is a scientific procedure that studies specific parts of your DNA. It helps to identify if you have certain genetic changes that may increase your risk of developing specific health conditions.

This service was performed 143 times for 142 patients

Gene analysis (peripheral myelin protein 22), full sequence analysis

Gene analysis of peripheral myelin protein 22 involves studying the full sequence of this specific gene. This analysis helps identify any genetic variations that may lead to certain health conditions. It's a non-invasive test involving a simple blood draw or saliva sample.

This service was performed 107 times for 107 patients

Gene analysis (poly[a] binding protein nuclear 1) for abnormal alleles

Gene analysis for Poly(A) Binding Protein Nuclear 1 (PABPN1) checks for abnormal alleles or variations in your DNA. This test can help identify genetic disorders caused by these variations. It's a non-invasive procedure, involving a simple blood or saliva sample.

This service was performed 108 times for 108 patients

Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis

Gene analysis, specifically postmeiotic segregation increased 2 (s cerevisiae) full sequence analysis, is a scientific procedure. It involves studying your entire genetic code to identify any changes or differences that could be related to certain health conditions. This is done in a lab, using a sample provided by you.

This service was performed 510 times for 510 patients

Gene analysis (serpin peptidase inhibitor, clade a, alpha-1 antiproteinase, antitrypsin, member 1) common variants

Gene analysis for SERPINA1 common variants is a test that checks for changes in the SERPINA1 gene. This gene helps protect your lungs and liver from damage. Certain changes can lead to conditions like lung disease or liver problems. This test helps identify those changes.

This service was performed 14 times for 14 patients

Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant

Gene analysis for the solute carrier organic anion transporter family, member 1b1 (SLCO1B1), common variant, is a test that examines your DNA to identify variations in the SLCO1B1 gene. This gene plays a crucial role in the body's ability to process certain medications.

This service was performed 62 times for 62 patients

Gene analysis (sphingomyelin phosphodiesterase 1, acid lysosomal) common variants

Gene analysis of sphingomyelin phosphodiesterase 1, acid lysosomal, involves studying specific variants in your genes. This helps understand your body's enzyme production, which can influence health conditions. It's a non-invasive procedure using a simple blood or saliva sample.

This service was performed 14 times for 14 patients

Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion

Gene analysis for survival of motor neuron 1 (SMN1) involves studying your DNA to identify changes or deletions in the SMN1 gene. This gene plays a key role in motor neuron health. Alterations can lead to conditions like spinal muscular atrophy. The process is safe and non-invasive.

This service was performed 109 times for 109 patients

Gene analysis (transforming growth factor beta-induced) for common variants

Gene analysis for common variants in the transforming growth factor beta-induced (TGFBI) gene helps understand your genetic makeup better. This procedure checks for variations in the TGFBI gene, which can influence your health. It's a safe, non-invasive test that uses a simple blood or saliva sample.

This service was performed 40 times for 40 patients

Gene analysis panel for evaluation of genes associated with epilepsy

A gene analysis panel for epilepsy evaluates specific genes linked to this condition. This test can help understand your epilepsy type and severity, potentially guiding treatment options. It involves a blood sample and lab analysis.

This service was performed 100 times for 100 patients

Molecular pathology procedure level 1

A Molecular Pathology Procedure Level 1 is a lab test that studies the genes in your cells. It helps identify alterations in your DNA that may cause or contribute to certain diseases. The procedure is non-invasive and helps in early disease detection.

This service was performed 859 times for 419 patients

Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count

This service provides a FDA-approved COVID-19 test kit for personal use. The test is self-administered and self-collected, meaning you conduct the test yourself. The kit contains all necessary items for one test. Follow the instructions carefully to ensure accurate results.

This service was performed 98,046 times for 2,953 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 14 times for 14 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
45D2257672
Facility Type
Independent
Certificate Effective Date
April 25, 2025
Certificate Expiration Date
April 24, 2027
Laboratory Director
DR. KEROLLOS A. SHAKER
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Elixir Diagnostics, Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for ELIXIR DIAGNOSTICS, LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1932843836, we treat the final digit (6) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 74. The final step is to find the difference between that total and the next multiple of ten (80 - 74 = 6).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
9
Unchanged
Pos 3
3
Doubled → 6
Pos 4
2
Unchanged
Pos 5
8
Doubled → 16 → 1 + 6
Pos 6
4
Unchanged
Pos 7
3
Doubled → 6
Pos 8
8
Unchanged
Pos 9
3
Doubled → 6
Check
6
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 3 → 6 8 → 16 → 7 3 → 6 3 → 6

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 9 + 6 + 2 + 1 + 6 + 4 + 6 + 8 + 6 + 24 = 74

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 74 is 80. The difference is the calculated check digit.

80 - 74 = 6
This NPI is valid
The calculated check digit is 6, which matches the last digit of 1932843836.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1932843836, enumerated as an "organization" on April 26, 2022.

The provider is located at 17115 RED OAK DR STE 123 HOUSTON, TX 77090 and the phone number is (979) 487-8258.

Clinical Medical Laboratory with taxonomy code 291U00000X.